Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1

First line targeted therapies in breast cancer: focus on bevacizumab || FREE PAPER ||

       
Total article views   HTML views PDF downloads Totals
7,287 Dovepress* 7,287+ 1,968 9,255
Totals 7,287 1,968 9,255
*Since 15 August 2007
+Since July 2016

View citations on Google Scholar